Stock & Company Details
Enliven Therapeutics Inc $ELVN
Price:
46,691,331
61M
$3.6B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Services
ELVN technical indicators
Latest Enliven Therapeutics Inc (ELVN) technical indicators as of 2026-07-01: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
61.92 10.1%
MACD:
2.73 2.3%
SMA 50:
$42.32 0.1%
SMA 200:
$29.39 0.5%
EMA 20:
$45.41 0.8%
Bollinger Bands:
54.92 / 31.70
Stochastic:
87.27 8.5%
ADX 14:
35.92 0.4%
ATR 14:
2.96 2.0%
CCI 20:
85.36 24.8%
OBV:
104.97M 1.1%
ROC 12:
5.70% 77.9%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially best-in-class or first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases.
Finance Bot
Ask your questions
Start by typing a question below.
